Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 5, 2003, Pages 32-37

  Fawcett, Jan A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MIANSERIN; NORTRIPTYLINE; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; DELUSIONAL DEPRESSION; DEPRESSIVE PSYCHOSIS; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOOD DISORDER; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOTHERAPY; REFRACTORY DEPRESSION; REFRACTORY MAJOR DEPRESSION; SUICIDE; SUPPORT GROUP;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DELUSIONS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; TREATMENT OUTCOME;

EID: 0037965939     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Angst J, Baastrup P, Grof P, et al. The course of monopolar depression and bipolar psychoses. Psychiatr Neurol Neurochir 1973;76:489-500
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-1442
3. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
4. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder [Revision]. Am J Psychiatry 2002; 159:1-50
5. Coppen AC. Lithium in unipolar depression and the prevention of suicide. J Clin Psychiatry 2000;61(suppl 9):52-56
6. Zornberg GL, Pope HG. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
7. Compton MT, Nemeroff CB. The treatment of bipolar depression. J Clin Psychiatry 2000;61(suppl 9):57-67
8. Baldessarini RJ, Tondo L. Does lithium treatment still work? evidence of stable responses over three decades. Arch Gen Psychiatry 2000;57:187-190
9. Klein DF, Davis JM. Diagnosis and Drug Treatment of Psychiatric Disorder. Baltimore, Md: Williams and Wilkins; 1969
10. de Montigny C, Cournoyer G, Morissette R, et al. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry 1983;40:1327-1334
11. Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch Gen Psychiatry 1983;40:1335-1342
12. Price H, Charney DS, Heninger G. Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986;143:1387-1392
13. Katona CL, Abou-Saleh MT, Harrison DA, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995; 166:80-86
14. Zullino D, Baumann P. Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors. Pharmacopsychiatry 2001;34:119-127
15. Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999;19:427-434
16. Rouillon F, Gorwood P. The use of lithium to augment antidepressant medication. J Clin Psychiatry 1998;59(suppl 5):40-41
17. Bohacek N, Bunney WE, Coppen A, et al. Pharmacotherapy of depressive disorders: a WHO consensus statement. J Affect Disord 1989; 17:197-198
18. Montgomery SA, Racagni G, Coppen A, et al. Impact of neuropharmacology in the 1990s: strategies for the therapy of depressive illness. Task force of the Collegium Internationale Neuro-Psychopharmacologicum (CINP). Eur Neuropsychopharmacol 1993;3:153-156
19. Nierenberg AA, Price LH, Charney DS, et al. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression. J Affect Disord 1990; 18:167-175
20. Shergill SS, Robertson MM, Stein G. Outcome in refractory depression. J Affect Disord 1999;54:287-294
21. Fieve RR, Dunner DL, Kumbarachi T, et al. Lithium carbonate in affective disorders, 4: a double-blind study of prophylaxis in unipolar recurrent depression. Arch Gen Psychiatry 1975;32:1541-1544
22. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-1307
23. Nierenberg AA, Papakostas GI, Petersen T, et al. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. J Clin Psychopharmacol 2003;23:92-95
24. Pai M, White AC, Deane AG. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 1986; 148:736-738
25. Price LH, Conwell Y, Nelson JC. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 1983;140:318-322
26. Baastrup PC, Schou M. Lithium as a prophylactic agent. Arch Gen Psychiatry 1967;16:162-172